Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

Delayed Data
As of 4:00pm ET
 +0.30 / +0.94%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 49.00, with a high estimate of 80.00 and a low estimate of 27.00. The median estimate represents a +51.70% increase from the last price of 32.30.

Analyst Recommendations

The current consensus among 19 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -96.05%
Growthannually -11.49%


Growthquarterly -5.01%
Growthannually 8.56%
Key to the earnings and sales forecast charts.